Aytu Biopharma Inc (AYTU) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aytu Biopharma Inc  (NASDAQ: AYTU)


Aytu Biopharma Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aytu Biopharma Inc's ROI in the fourth quarter of 2026?
Aytu Biopharma Inc recorded a cumulative net loss of $-14 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -26.66%.

Within the Healthcare sector 353 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3847, from total ROI ranking in the third quarter of 2026 at 4312.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM 3.93 % 6.18 % 12.14 % 1.11 % -8.8 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 57 47 56 54 56
Return On Investment (TTM) -26.66 % -63.86 % -45.48 % -24.88 % -26.37 %
AYTU's Overall Ranking # 3847 # 4312 # 3512 # 3560 # 1614
Seq. Investment Change TTM 0.25 % -0.78 % 2.31 % 2.13 % 2.42 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -14 -34 -24 -13 -14

AYTU Company Profile >> Back to AYTU Roi Comparisons >> See Annual AYTU Return On Investment



Return On Investment AYTU's Ranking
Within: No.
Industry # 134
Sector # 354
Overall # 3847

Return On Investment Statistics
High Average Low
1659.97 %
-39.63 %
-271.24 %
(Mar 31 2015)   (Mar 31 2017)







Financial Statements
Aytu Biopharma Inc's IV. Quarter Investments $ 57 Millions AYTU's Balance sheet
Aytu Biopharma Inc's IV. Quarter Income $ 0 Millions Quarterly AYTU's Income Statement
AYTU's Income by Division See AYTU's Income by Division


AYTU Annual Return On Investment (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Investments in Millions 57 56 51 67 73
Y / Y Investment Growth 0.96 % 9.46 % -23.89 % -7.83 % -53.16 %
Net Income in Millions -14 -14 -16 -17 -110
Y / Y Net Income Growth - - - - -
Annual Return On Investment -25.12 % -24.13 % -30.86 % -25.28 % -150.55 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AYTU's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AYTU's Competitors
Subscribers only: Roi for Aytu Biopharma Inc's Suppliers
Subscribers only: Return On Investment for AYTU's Customers

Other Ratios
AYTU's Roa AYTU's Inventory Turnover Ratio AYTU's Growth Rates AYTU's Dividend Statistics
AYTU's Profitability Ratios AYTU's Asset Turnover Ratio AYTU's Dividend Growth
AYTU's Roe AYTU's Valuation Ratios AYTU's Financial Strength Ratios AYTU's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T08:02:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.